Poland· PL-100013330
Cefaleksyna TZF
A cefalexin product containing cefalexinum, registered in Poland by Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Cefalexin is registered in 14 of 19 countries.
Countries holding a registration under ATC J01DB01 (cefalexin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Cefalexin · ATC J01DB01
14 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cefalexin costs, country by country.
Normalised to the WHO defined daily dose (2 g), the median price runs from $0.72 in United States to $1.28 in Spain — a ×1.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Cefalexin · price per daily dose (2 g)
USD · FX 28 Sept 2026
- ES Spain$1.28
- US United States$0.72 (acquisition cost)
The record
At a glance
URPL (Poland)- Active substance
- Cefalexinum
- Manufacturer
- Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- Country
- Poland (PL)
- ATC code
- J01DB01
- ATC class
- Cefalexin
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990657216
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
223 interactions on record for cefalexin.
Graded by severity as the source publishes them — 13 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefalexin · interactions on record
223 records
- 13 moderate
- 210 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- BalsalazideA07EC04moderate
- MetforminA10BA02moderate
- DicoumarolB01AA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefalexin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCephalexinA-S Medication Solutions
- United KingdomCefalexin 500mg capsulesLupin Healthcare (UK) Ltd
- SpainCEFALEXINA NORMON 500 mg CAPSULAS DURASLaboratorios Normon S.A.
- CanadaTEVA-CEPHALEXINTEVA CANADA LIMITED
- FinlandXefalAntibiotice SA
- IrelandKeflex 125 mg/5 ml Powder for Oral SuspensionFlynn Pharma Limited
- GermanyCefalexin Reiwa HealthcareReiwa Healthcare S.L
- ItalyCEPOREX*8 cpr rivestite 1 gTEOFARMA Srl
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Cephalobene, Keflex
- Belgium · Keforal
- Bulgaria · Оспексин
- Cyprus · Felexin, Keflex
- Germany · Cefalexin Reiwa Healthcare, Cephalex-Ct
- Denmark · Keflex
- Spain · Cefalexina Normon, Cefalexina Reiwa Healthcare
- Finland · Kefalex, Kefexin
- France · Keforal, Kéforal
- United Kingdom (Northern Ireland) · Cefalexin, Cefalexin Ascend Laboratories (Uk)
- Croatia · Cefaleksin Belupo, Cefalexin Alkaloid
- Hungary · Cefalexin Reiwa Healthcare, Pyassan 250 Mg Kemény Kapszula
- Ireland · Keflex
- Italy · Ceporex, Keforal
- Luxembourg · Keforal
- Malta · Keflex
- Netherlands · Keforal
- Norway · Keflex
- Romania · Cefalexină Arena, Cefalexina Atb
- Slovakia · Ospexin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/25d14276-0636-4881-bd56-9262af7303b7 GET /v1/drugs/25d14276-0636-4881-bd56-9262af7303b7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "500 mg",
"packaging": "05909990657216 ¦ Rp ¦ 58047\n16 kaps.",
"substance": "Cefalexinum monohydricum 500 mg",
"common_name": "Cefalexinum",
"pl_product_id": "100013330",
"pozwolenie_nr": "06572",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about cefalexin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.